Segments
Neurology
Specialization in medicine dealing with nervous diseases
Neurology
Early stroke detection
Cerebrovascular diseases are the third most common
Causes of death worldwide. According to an official statement by the WHO
up to six million people die from it every year.
However, up to now there is no reliable biomarker
which can detect a stroke at an early stage.
New opportunities
Diagenics has developed a method that makes it possible
power to measure strokes using a biomarker:
Glycogen Phosphorylase Isoenzyme BB (GPBB).
This enzyme is specific for the heart and the brain,
which in the case of ischemia released into the bloodstream
becomes - much earlier than all necrosis markers.
15.000.000
STROKE PATIENTS
RISK FACTORS:
HIGH BLOOD PRESSURE UNHEALTHY LIFESTYLE OVERWEIGHT GENETIC CONDITIONS
Diagenics has patented antibodies to this
Enzyme and already has a new line of products for early diagnosis
Developed from strokes: DIASTROKE®.
The product was made based on the above
Study CE registered. Future studies will be ours
Expertise in the field of stroke diagnosis
expand.
Neurology
Our Products
DIASTROKE® POCT
DIAGENICS Group SE
DIASTROKE® ELISA
DIAGENICS Group SE
DIASTROKE® READER
DIAGENICS Group SE